Empagliflozin Functional Capacity - Non-Interventional Study
Empagliflozin Functional Capacity - Non-Interventional Study
This is a multinational non-interventional study based on newly collected data to assess demographics, disease, and treatment pattern of patients with chronic Heart Failure (HF) in a two-cohort design: one cohort will receive first prescription of empagliflozin as routine therapy for HF, the other cohort will receive HF therapy with drugs with another mechanism of action. Treatment of HF according to routine practice is determined by the physician independent of the participation of the patient in this non-interventional study.
Inclusion Criteria:
Exclusion Criteria:
Ostrava - Poruba, 708 52, Czechia
Třinec Podlesí, 73961, Czechia
Chorozow, 41500, Poland
Iwanowice Włościańskie, 32-095, Poland
Koszalin, 75-604, Poland
Krakow, 31-826, Poland
Kranse, 36-007, Poland
Rybnik, 44-203, Poland
Zabrze, 41-800, Poland
Com Mosoaia, 117512, Romania
Sat Rosu, Comuna Chiajna, 077041, Romania
Tifgu Mures, 540281, Romania
Will, 9500, Switzerland